InvestorsHub Logo
Followers 26
Posts 4467
Boards Moderated 0
Alias Born 03/28/2005

Re: None

Thursday, 12/24/2020 9:30:41 AM

Thursday, December 24, 2020 9:30:41 AM

Post# of 36578
Revive Therapeutics aims to file for an Emergency Use Authorization (“EUA”) of Bucillamine for mild to moderate COVID-19 with the FDA http://thestocksmarket.net/2020/12/24/revive-therapeutics-aims-to-file-for-an-emergency-use-authorization-eua-of-bucillamine-for-mild-to-moderate-covid-19-with-the-fda/